St. John's Wort

An option for the primary care treatment of depressive patients?

Abstract.

This article reviews the historical background, active ingredients of St. John's Wort and the major double-blind placebo-controlled studies. Despite the two major failed clinical trials conducted in American Research Centers, most of the data reviewed support that hypericum extracts are more effective than placebo for the treatment of mild to moderate depressive illness. The authors examine the likely reasons for the failed studies and also describe drug interactions and the side effects of St. John's Wort. Those patients who are prescribed St. John's Wort should be closely monitored.

This is a preview of subscription content, log in to check access.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Prof.Dr. H.-J. Möller.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Gupta, R., Möller, H. St. John's Wort. European Archives of Psychiatry and Clinical Neurosciences 253, 140– 148 (2003). https://doi.org/10.1007/s00406-003-0417-6

Download citation

Key words

  • St. John's Wort
  • Hypericum
  • randomised double-blind controlled studies
  • depression